Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Picker: An Attenuated CMV Vector |
| Strategy: | Vector vaccines (viral or bacterial) |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2014-09-09 |
| Study Made Public: | 2017-02-08 |
Title
Humoral response in an NHP vaccination model using RhCMV/SIV followed by homologous or heterologous challenge
Description
CAVD 460 is a non-human primate challenge study to compare immunogenicity and protection following administration with CMV/SIV vector immunogens, delta-pp71 RhCMV/SIVmac239 versus delta-pp71 RhCMV/SIVsmE660.
Sign in to see full information about this study and to download study data.
Products
SIVmac239 delta-pp71 RhCMV/SIVmac239 delta-pp71 RhCMV/SIVsmE660Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.